Compare CRDO & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRDO | HLN |
|---|---|---|
| Founded | 2008 | 2022 |
| Country | Cayman Islands | United Kingdom |
| Employees | N/A | 24524 |
| Industry | Semiconductors | Package Goods/Cosmetics |
| Sector | Technology | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.7B | 41.1B |
| IPO Year | 2022 | N/A |
| Metric | CRDO | HLN |
|---|---|---|
| Price | $256.37 | $9.77 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 1 |
| Target Price | ★ $179.62 | N/A |
| AVG Volume (30 Days) | 7.6M | ★ 9.2M |
| Earning Date | 06-01-2026 | 02-26-2026 |
| Dividend Yield | N/A | ★ 1.94% |
| EPS Growth | ★ 765.52 | N/A |
| EPS | ★ 2.51 | N/A |
| Revenue | ★ $1,335,116,000.00 | N/A |
| Revenue This Year | $210.92 | $6.55 |
| Revenue Next Year | $57.22 | $4.42 |
| P/E Ratio | $102.67 | ★ $49.05 |
| Revenue Growth | ★ 205.68 | N/A |
| 52 Week Low | $86.49 | $8.65 |
| 52 Week High | $308.67 | $11.28 |
| Indicator | CRDO | HLN |
|---|---|---|
| Relative Strength Index (RSI) | 52.69 | 63.41 |
| Support Level | $212.83 | $9.62 |
| Resistance Level | $308.67 | $10.05 |
| Average True Range (ATR) | 25.00 | 0.12 |
| MACD | -2.87 | 0.07 |
| Stochastic Oscillator | 37.29 | 83.97 |
Credo Technology Group Holding Ltd provides connectivity solutions for AI-driven applications, cloud computing, and hyperscale networks. Its high-speed copper and optical interconnect products support data infrastructure demands. The Company's product portfolio includes ZeroFlap (ZF) Active Electrical Cables (AECs), ZF optical transceivers, OmniConnect memory solutions, and retimers and DSPs for optical and copper Ethernet and PCIe, leveraging the PILOT diagnostic and analytics software platform. Its products are based on Serializer/Deserializer (SerDes) and Digital Signal Processor (DSP) technologies and include integrated circuits (ICs), Active Electrical Cables (AECs), SerDes Chiplets, and SerDes IP licensing solutions. The United States generates the maximum revenue.
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.